Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Adjuvant Docetaxel in Breast Cancer With Isolated Tumor Cells in Bone Marrow
NCT00248703Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Oct 2003
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Oslo University Hospital. Started Oct 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00248703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248703.